197 related articles for article (PubMed ID: 8319241)
1. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.
Thanhäuser A; Böhle A; Flad HD; Ernst M; Mattern T; Ulmer AJ
Cancer Immunol Immunother; 1993 Jul; 37(2):105-11. PubMed ID: 8319241
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon.
Böhle A; Thanhäuser A; Ulmer AJ; Ernst M; Flad HD; Jocham D
J Urol; 1993 Dec; 150(6):1932-7. PubMed ID: 8230540
[TBL] [Abstract][Full Text] [Related]
4. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
Liu W; O'Donnell MA; Chen X; Han R; Luo Y
Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
[TBL] [Abstract][Full Text] [Related]
5. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
6. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.
Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ
Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
[TBL] [Abstract][Full Text] [Related]
8. The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.
Thanhäuser A; Böhle A; Schneider B; Reiling N; Mattern T; Ernst M; Flad HD; Ulmer AJ
Cancer Immunol Immunother; 1995 Feb; 40(2):103-8. PubMed ID: 7882379
[TBL] [Abstract][Full Text] [Related]
9. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines.
Wang MH; Chen YQ; Gercken J; Ernst M; Böhle A; Flad HD; Ulmer AJ
Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400
[TBL] [Abstract][Full Text] [Related]
10. On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cells.
Böhle A; Thanhäuser A; Ulmer AJ; Mattern T; Ernst M; Flad HD; Jocham D
Urol Res; 1994; 22(3):185-90. PubMed ID: 7527607
[TBL] [Abstract][Full Text] [Related]
11. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
Hermann GG; Petersen KR; Steven K; Zeuthen J
J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
[TBL] [Abstract][Full Text] [Related]
12. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.
Shemtov MM; Cheng DL; Kong L; Shu WP; Sassaroli M; Droller MJ; Liu BC
J Urol; 1995 Jul; 154(1):269-74. PubMed ID: 7776443
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
Ozdemir O; Ravindranath Y; Savaşan S
J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro.
Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT
Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153
[TBL] [Abstract][Full Text] [Related]
15. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
Luo Y; Yamada H; Evanoff DP; Chen X
Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
[TBL] [Abstract][Full Text] [Related]
16. Activation of natural killer cells by Bacillus Calmette-Guérin.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):518-24. PubMed ID: 11464031
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lymphocytic responses after treatment with Bacillus Calmette-Guerin and interferon-alpha 2b for superficial bladder cancer.
Gan YH; Mahendran R; James K; Lawrencia C; Esuvaranathan K
Clin Immunol; 1999 Feb; 90(2):230-7. PubMed ID: 10080835
[TBL] [Abstract][Full Text] [Related]
18. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
[TBL] [Abstract][Full Text] [Related]
19. Bacillus-Calmette-Guérin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion.
Durek C; Brandau S; Ulmer AJ; Flad HD; Jocham D; Böhle A
J Urol; 1999 Aug; 162(2):600-5. PubMed ID: 10411094
[TBL] [Abstract][Full Text] [Related]
20. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
